DCM
KURA icon

Driehaus Capital Management’s Kura Oncology KURA Stock Holding History

Driehaus Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-264,295
Closed -$8.63M – 479
2020
Q4 		$8.63M Buy
+264,295
New +$9.29M 0.14% 195
2020
Q2 		– Sell
-30,000
Closed -$299K – 437
2020
Q1 		$299K Sell
30,000
-10,000
-25% -$114K 0.01% 349
2019
Q4 		$550K Sell
40,000
-425,588
-91% -$6.31M 0.01% 382
2019
Q3 		$7.06M Buy
465,588
+107,656
+30% +$1.92M 0.23% 116
2019
Q2 		$7.05M Buy
+357,932
New +$5.94M 0.22% 125

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Driehaus Capital Management's KURA Position: Q1 2021 in Review

Driehaus Capital Management sold out of Kura Oncology (KURA) in Q1 2021, closing a stake of 264,295 shares — an estimated $8.63M sold.

Driehaus Capital Management first reported a position in KURA in Q2 2019 and held it in 5 quarters. The position peaked at $8.63M in Q4 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q1 2021.

  • Driehaus Capital Management reported no remaining Kura Oncology position as of Q1 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 264,295 Kura Oncology shares in Q1 2021, an estimated $8.63M.
  • Driehaus Capital Management first reported a position in Kura Oncology in Q2 2019 and held it in 5 quarters.
  • Driehaus Capital Management's Kura Oncology position peaked at $8.63M in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2021.

Based on Driehaus Capital Management's 13F filing for Q1 2021, filed 17 May 2021.